Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06121843
Title A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham RECRUITING Birmingham Alabama 35294-3300 United States Details
City of Hope Comprehensive Cancer Center NOT_YET_RECRUITING Duarte California 91010 United States Details
Beth Israel Deaconess Medical Center NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Local Institution - 0010 NOT_YET_RECRUITING Omaha Nebraska 68198 United States Details
Laura and Isaac Perlmutter Cancer Center RECRUITING New York New York 10016 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Local Institution - 0023 WITHDRAWN Pittsburgh Pennsylvania 15232 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field